Fundraising Fox

Jim Wells

Investor

Scientific Advisory Board Member — Former Chair, UCSF Pharmaceutical Chemistry at Red Tree Venture

About

Jim Wells holds a Ph.D. in biochemistry from Washington State University and completed postdoctoral work at Stanford University School of Medicine. He began his research career in 1982 as a co-founding member of the Protein Engineering Department at Genentech, later co-founded Sunesis Pharmaceuticals as CSO and president, and in 2005 joined the UCSF faculty in Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, where he founded the Small Molecule Discovery Center and chaired the Department of Pharmaceutical Chemistry. His lab studies how cell surface proteomes change in health and disease, and he has co-founded several companies, most recently EpiBiologics.

Investments

Investor

EpiBiologicsSunesis Pharmaceuticals

Per the firm's website.

Colleagues at Red Tree Venture

Adam Silverman
Red Tree Venture Labs Biologics at Red Tree Venture
Antonio Lepore
Senior Associate at Red Tree Venture
Ariell Ortega
Executive Assistant at Red Tree Venture
Bill Robinson
Scientific Advisory Board - Immunology; Chief, Stanford Division of Immunology and Rheumatology at Red Tree Venture
Brian Stearns
Red Tree Venture Labs Chemistry at Red Tree Venture
Cassie Lue
VP of Investor Relations at Red Tree Venture
Crystal Mackall
Scientific Advisory Board - Oncology; Director, Stanford Center for Cancer Cell Therapy at Red Tree Venture
Deborah Nguyen
Red Tree Venture Labs Operating Partner at Red Tree Venture